October, Breast Cancer Awareness Month, symbolizes a sense of community for individuals with breast cancer, however the experiences of those living with metastatic breast cancer (MBC), the most advanced stage of the disease, is rarely discussed.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/mbcad/40557/
Duration : 5 min 21 sec
A collaboration of Kim Mosley and Mary Seager for the Forum of Contemporary Art, St. Louis. Mary was diagnosed with stage 4 metastatic breast cancer with multiple liver lesions in 1993. She had nine months of high dose CAF and then a BMT/PSCT in 1994. The exhibit traveled to Maryville University in St. Louis and University of Missouri, Columbia.
Duration : 0:6:27
This is my electronic press kit, the story of a breast cancer warrior who was diagnosed (but initially MISdiagnosed) at the age of 30 with STAGE 4 metastatic breast cancer. She was given one year to live.
Duration : 0:7:56
Lucia Lizotte. After 8 months of Issels Treatment bone metastases of sternum disappeared and 4 of 5 liver metastases gone. February 2008, Lucia in her own words: I thank God that my husband and I made the decision to come to Issels.
Duration : 0:1:54
http://www.trusera.com/health/collections/breast-cancer
This is Michele Hyra, mom to two little girls, wife to Matt, and fighting breast cancer every day. In July 2007, she was told she had 11 months to live. She’s still here. Hear the story of her Stage 4 metastatic breast cancer with lymph node involvement and extensive metastasis to the skeleton. Listen as Michele shares how she found her first lumps, talked to her daughters about breast cancer, proposes huge changes to the medical system, and has found peace in the midst of it all. Presented by Trusera, the online network where you can find and share real-world experiences with others who have been there. Come. Listen. Share.
Duration : 0:5:45
Even though most women know the importance of early detection and yearly screenings in the fight against breast cancer, each year thousands receive a devastating diagnosis of stage four breast cancer. In fact, each year more than one-in-four breast cancer patients are diagnosed with a highly aggressive breast cancer known as HER-2 neu positive, which until recently was considered seldom treatable.
Now a new therapy monitoring test, Siemens HER-2/neu blood test, is giving renewed hope to metastatic breast cancer patients. The test is the only FDA cleared serum HER-2/neu blood test, which can indicate whether metastatic breast cancer is progressing or responding to treatment. By combining advanced drug therapies, routine mammograms, advanced breast ultrasounds and MRIs, doctors have been able to fight many metastatic cancers more effectively.
Source: Siemens
Duration : 0:1:57